BROWSE

AJOU Open Repository

Browsing by Ajou Author

researcher image email
안, 미선(Ahn, Mi Sun) Currently indexed
[School of Medicine / Graduate School of Medicine] - [Hematology-Oncology]

Author IDs

ORCID
-
ISNI
0000000472420768
WOS
-
SCOPUS
-
Research areas
Co-Researcher

Showing results 1 to 20 of 51

This table browses all dspace content
Pub YearTitleAuthor(s)
2023A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13)안미선
2023Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer안미선
2023Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen안미선
2022237 (PB117) - A phase II study to evaluate the efficacy of regorafenib in C-KIT mutated metastatic malignant melanoma patients who have progressed on first-line treatment: A Multicenter Trial of Korean Cancer Study Group (UN-14–13)안미선
2022Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations안미선
2022The efficacy of EGFR-tyrosine kinase inhibitor in non-small cell lung cancer patients with synchronous brain metastasis: a real-world study강석윤, 김세혁, 노오규, 노태훈, 신승수, 안미선, 오영택, 이현우, 최용원, 최진혁
2022Erratum: Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin강석윤, 김철호, 김태환, 신승수, 신유섭, 안미선, 오영택, 이현우, 장전엽, 최용원, 최진혁, 허재성
2022Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin강석윤, 김철호, 김태환, 신승수, 신유섭, 안미선, 오영택, 이현우, 장전엽, 최용원, 최진혁, 허재성
2022Analysis of treatment outcomes according to the cycles of adjuvant chemotherapy in gastric cancer: a retrospective nationwide cohort study강석윤, 김태환, 안미선, 이현우, 최용원, 최진혁
2022Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18–14/KM10B)안미선
2022Analysis of thromboembolic events in patients with non-small cell lung cancer who received adjuvant chemotherapy: single-center real-world data강석윤, 김태환, 신승수, 안미선, 이현우, 최용원, 최진혁
2021Factors to improve distress and fatigue in Cancer survivorship; further understanding through text analysis of interviews by machine learning김지나, 안미선, 전미선
2021Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data강석윤, 김태환, 신승수, 안미선, 이현우, 조헌도, 최용원, 최진혁
2021Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia강석윤, 김태환, 박준성, 안미선, 이현우, 정성현, 최용원, 최윤석, 최진혁
2021Development of population-based cancer indicators and a measurement of cancer care continuum using a modified delphi method박진희, 안미선, 전미선, 정승연, 조오연
2021Clinicopathological and Molecular Analysis of 45 Cases of Pure Mucinous Breast Cancer강석윤, 김장희, 김태규, 노진, 안미선, 임현이, 정용식, 최진혁
2020Erratum: Osimertinib for patients with non–small-cell lung cancer harboring uncommon EGFR mutations: A multicenter, open-label, phase II trial (KCSG-LU15-09) (Journal of Clinical Oncology (2020) DOI: 10.1200/JCO.19.00931)안미선
2020Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07안미선
2020Combination versus single-agent as palliative chemotherapy for gastric cancer강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁
2020Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)안미선
1 2 3
  • License
    sherpa_romeo
    sherpa_juliet

OAK

Ajou University Medical Information & Media Center 164 Worldcup-ro Yeongtong-gu Suwon 16499 Korea / TEL : 031-219-5312
Copyright (c) Ajou University Medical Information & Media Center All Rights Reserved.
AJOU Open Repository는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Guide 아주대학교 의학문헌정보센터